"LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia

Clinical trial NCT02074657 · COMPLETED

Trial details

NCT number

NCT02074657

Sponsor

Hospital Universitario La Paz

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2014-04-01

Primary completion

2016-09-01

Enrollment

13

View on ClinicalTrials.gov